Nebilong
Nebilong is nebivolol 2.5 mg tablets — ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Starter strength for elderly or renal-impaired patients. For hypertension and elderly heart failure (SENIORS trial). Favourable on glucose, lipids, and erectile function vs older beta-blockers.
✓ Lékařsky ověřeno Morgan Ellis — Pharmacy Researcher · 8 years experience Last reviewed: May 2026
⚡ Quick Answer — What is Nebilong?
Nebilong je 2.5 mg nebivolol tablet from a WHO-GMP certified manufacturer — ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Primary use is hypertension; also used for angina, arrhythmia control, post-myocardial-infarction secondary prevention. Preferred in elderly, metabolic syndrome, and patients with erectile dysfunction. Typical hypertension dose: 5 mg once daily (range 2.5-10 mg). Start 2.5 mg in elderly or renal impairment. Contraindicated in asthma (relative for cardioselective agents; absolute for non-selective), severe bradycardia, second/third-degree heart block, acute decompensated heart failure, and phaeochromocytoma without prior alpha-blockade. Do NOT stop abruptly — taper over 1-2 weeks to avoid rebound tachycardia / angina / MI.
📦 Každá objednávka je pokryta naší Zárukou opětovného odeslání — pokud vaše zásilka nedorazí do 20 pracovních dnů, přeposíláme ji.
Proč objednávat z MedsBase
Naše generické léky pocházejí od výrobců certifikovaných WHO-GMP a jsou expedovány po celém světě v diskrétním, nenápadném balení – na vnější straně balíku není uveden název léku. Platby kartou jsou směrovány prostřednictvím regulovaného procesoru (popisky na výpisu zahrnují regulovaného procesora plateb kartou – nikdy “MedsBase” nebo název léku). Přijímáme také kryptoměny a bankovní převody SEPA. Každá objednávka je zajištěna naší politikou přeposlání.
What Is Nebilong?
Nebilong is an oral tablet containing nebivolol 2.5 mg from a WHO-GMP certified manufacturer, supplied in 30-180 tablets. Nebivolol is a ultra-selective beta-1 blocker with additional nitric-oxide-mediated vasodilation. Third-generation beta-blocker with the highest beta-1 selectivity of any clinically-used agent (roughly 10× more selective than bisoprolol) and a unique property: it releases nitric oxide in the vascular endothelium, producing direct vasodilation. Evidence from the SENIORS trial for elderly heart failure (heart failure with preserved ejection fraction included — unusual for a beta-blocker).
How Nebivolol Lowers Blood Pressure
Beta-blockers reduce blood pressure through four mechanisms:
- Reduction of cardiac output — beta-1 blockade in the sinoatrial node reduces heart rate, and blockade in ventricular myocardium reduces contractility. Lower cardiac output = lower blood pressure.
- Renin-angiotensin suppression — beta-1 blockade in juxtaglomerular cells reduces renin release, lowering angiotensin II and aldosterone over 2-4 weeks. This accounts for much of the long-term BP effect.
- Central sympathetic reduction — lipophilic beta-blockers cross the blood-brain barrier and reduce central sympathetic outflow.
- Nitric-oxide-mediated vasodilation (nebivolol-specific) — endothelial NO release produces direct arterial relaxation alongside the beta-blockade effect.
Beta-blockers are moderately lipophilic. Plasma half-life of nebivolol is 10-44 hours (depending on metaboliser status).
Approved and Evidence-Based Uses
- Hypertension (primary indication)
- Heart failure in elderly (>70 years) — SENIORS evidence
- Hypertension with metabolic syndrome — favourable on glucose/lipid profile vs older beta-blockers
- Hypertension in erectile-dysfunction patients — less sexual-dysfunction impact than propranolol / atenolol; in some studies, improved endothelial function improves erectile function
Nebilong Dosage
Adult hypertension dose: 5 mg once daily (range 2.5-10 mg). Start 2.5 mg in elderly or renal impairment.
Start low, titrate upward over 2-4 weeks to target BP (typically <140/90 in uncomplicated hypertension; <130/80 in diabetes, chronic kidney disease, or established cardiovascular disease). Check resting pulse before each dose-increase — do not titrate if <55 bpm.
Monitorování:
- Resting pulse and BP at 2, 4, and 8 weeks after starting or dose change
- Baseline ECG if any cardiac history; periodic ECG if symptoms change
Administration: swallow whole with water. Take at approximately the same time each day.
Discontinuation: NEVER stop abruptly. Taper over 1-2 weeks (reduce by 25-50% every 3-5 days). Abrupt discontinuation causes rebound tachycardia, worsened angina, and — in patients with coronary disease — can precipitate myocardial infarction. This is one of the most important safety points for beta-blockers.
Vedlejší účinky
Common (>5%):
- Fatigue, lethargy — often adapts over 2-4 weeks
- Cold hands and feet (peripheral vasoconstriction)
- Bradycardia (check pulse; stop if <50 bpm)
- Exercise intolerance — maximum heart rate is blunted by beta blockade
- Dizziness, postural hypotension
- CNS effects possible but less common than with propranolol
- Postural dizziness (more common due to vasodilator component)
Méně časté: depression, reduced libido / erectile dysfunction, gastrointestinal upset, Raynaud-like cold intolerance, bronchospasm (more common with non-selective agents).
Important but uncommon:
- Masked hypoglycaemia in diabetics — beta-blockers blunt the tachycardia / tremor warning signs of low blood sugar. Monitor glucose more carefully; prefer bisoprolol in insulin-treated diabetes.
- Bronchospasm — can be severe in asthma / COPD. Absolute contraindication for non-selective agents; relative for cardioselective.
- Heart block or worsening heart failure — in susceptible patients. Start low, titrate slowly.
Contraindications & Cautions
- Severe asthma / severe COPD — relative contraindication (cardioselectivity is relative, not absolute)
- Second or third-degree atrioventricular block (without pacemaker)
- Sinus bradycardia <50 bpm
- Cardiogenic shock, decompensated heart failure requiring inotropes
- Severe peripheral arterial disease, Raynaud’s syndrome (relative)
- Phaeochromocytoma without prior alpha-blockade — paradoxical hypertensive crisis (never use a beta-blocker before alpha-blocker)
- Severe hepatic impairment (for extensively hepatic-metabolised agents: propranolol, metoprolol, carvedilol, labetalol)
- Severe renal impairment — dose adjustment needed for renal-excreted agents (atenolol, nadolol)
- Hypersensitivity to nebivolol
Pregnancy: Category C; cross the placenta; small risk of intrauterine growth restriction, neonatal bradycardia, and hypoglycaemia. Use only if benefit clearly outweighs risk; labetalol is the pregnancy-preferred beta-blocker.
Breastfeeding: small amounts in breast milk; generally considered compatible with monitoring.
Interakce s léčivy
- Verapamil, diltiazem (non-dihydropyridine CCBs) — additive bradycardia, heart block, and negative inotropy; generally avoid combination. Dihydropyridine CCBs (amlodipine, nifedipine) are safer to combine with beta-blockers.
- Other beta-blockers — do not combine; additive bradycardia
- Clonidine — if stopping clonidine, stop the beta-blocker first (several days before) to avoid rebound hypertensive crisis
- Insulin and sulphonylureas — mask hypoglycaemia warning signs; monitor glucose closely
- NSAID — reduce the antihypertensive effect of beta-blockers; avoid chronic combination
- Alkohol — additive hypotension and CNS depression (particularly for lipophilic agents)
Beta-Blocker Class at a Glance
| Beta-blocker | Selectivity | Nejvhodnější pro |
|---|---|---|
| Propranolol (Inderal, Ciplar, Beloc) | Non-selective | Migraine, tremor, thyrotoxicosis, performance anxiety, HTN |
| Metoprolol | Cardioselective | Post-MI, HF-REF (succinate ER), angina, AF rate control |
| Carvedilol | Non-selective + α-1 | HF-REF (mortality evidence), post-MI |
| Bisoprolol | Highly cardioselective | HF-REF, HTN, angina, AF rate control |
| Nebivolol | Ultra-selective + NO | Elderly, metabolic syndrome, erectile dysfunction |
| Atenolol | Cardioselective (hydrophilic) | Angina, AF rate control (second-line for HTN) |
| Labetalol | Non-selective + α-1 | Pregnancy hypertension, hypertensive crisis |
Preferred beta-blocker in elderly patients, patients with metabolic syndrome or impaired glucose tolerance, and men with erectile dysfunction. Ultra-high beta-1 selectivity means it is generally tolerated in mild-to-moderate asthma (still not absolutely safe; use caution and monitor). NO-mediated vasodilation gives it a BP-lowering profile closer to a CCB than a classical beta-blocker.
Skladování
Store Nebilong below 25°C. Keep out of reach of children — accidental paediatric beta-blocker ingestion can cause life-threatening bradycardia and hypoglycaemia.
Často kladené dotazy
How long does Nebilong take to lower blood pressure?
You should see some BP reduction within 1-2 days of starting; the full antihypertensive effect takes 2-4 weeks (driven by the gradual renin-angiotensin suppression, not the immediate heart-rate effect). Measure BP at home at the same time each day to track response.
Can I take Nebilong if I have asthma?
Nebivolol is ultra-selective + NO release, so it is relatively safer in asthma than non-selective agents. However, cardioselectivity is relative — at higher doses beta-2 blockade can still occur. In severe or brittle asthma, avoid all beta-blockers if possible. In mild asthma or COPD, use with monitoring and inhaler access.
Why should I never stop Nebilong abruptly?
Abrupt discontinuation causes rebound tachycardia and worsened angina within 24-48 hours, driven by up-regulation of beta receptors during chronic blockade. In patients with coronary artery disease, this can precipitate myocardial infarction or unstable angina. Always taper over 1-2 weeks when stopping.
Will Nebilong affect my exercise performance?
Yes — beta blockade blunts the heart-rate response to exercise, so your maximum pulse is lower and you fatigue faster at high intensities. For recreational exercise most people adapt; for competitive endurance athletes, beta-blockers can meaningfully impair performance and are banned in precision sports (shooting, archery — where they reduce physiological tremor).
Will Nebilong affect my blood sugar if I have diabetes?
Beta-blokátory mask the tachycardia / tremor / palpitation warning signs of hypoglycaemia, making low blood sugar harder to detect. They can also blunt the counter-regulatory glucose response. Monitor glucose more frequently on a beta-blocker, particularly if on insulin or sulphonylureas. Nebivolol a bisoprolol have the best metabolic profile.
Can I drink alcohol on Nebilong?
Moderate alcohol is generally acceptable but alcohol potentiates the hypotensive and CNS-depressant effects. Stand up slowly after drinking. Alcohol is also an independent BP-raiser; reducing intake can improve BP control independent of Nebilong.
Does Nebilong cause weight gain?
Older beta-blockers (propranolol, atenolol, metoprolol) are associated with modest weight gain (1-3 kg) and worsening of insulin sensitivity over time. Nebivolol and carvedilol are weight-neutral or slightly weight-favourable due to their vasodilator components. For patients with metabolic syndrome, nebivolol is the preferred beta-blocker when one is needed.
Is Nebilong safe in pregnancy?
Category C. Use only if benefit clearly outweighs risk. For antihypertensive use in pregnancy, labetalol is the preferred beta-blocker; methyldopa and nifedipine are the two other pregnancy-safe options.
Can I take Nebilong with other BP medications?
Yes — beta-blockers combine well with dihydropyridine calcium-channel blockers (amlodipine), ACE inhibitory (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), and thiazide diuretics (HCTZ). Avoid combination with non-dihydropyridine CCBs (verapamil, diltiazem) — additive bradycardia and heart-block risk.
Where can I buy Nebilong online?
You can buy Nebilong (nebivolol 2.5 mg tablet, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.
Related Beta-Blockers & Antihypertensives
- Atenheal — Atenolol 25/50/100 mg
- Inderal LA — Propranolol 40 mg long-acting
- Labebet — Labetalol 100 mg (pregnancy-safe)
- Metolar — Metoprolol Tartrate 25/50/100 mg
- Nebicard — Nebivolol 2.5/5 mg
- Provanol SR — Propranolol 80 mg SR
- Browse all High Blood Pressure Medications
Související alternativy
Další produkty v Chronická onemocnění které zákazníci také prohlížejí:
Další možnosti v léčbě vysokého krevního tlaku
Řazeno podle nedávného objemu objednávek na MedsBase — co si ostatní zákazníci v této kategorii vybírají.
| Síla | 2,5 mg |
|---|---|
| Množství | 30 tablet/ks, 60 tablet/ks, 90 tablet/ks, 180 tablet/ks |
Nebilong
Otázky a odpovědi
Nebilong
Související produkty
Hodnocení
Zatím zde nejsou žádná hodnocení